" /> Olendalizumab - CISMeF





Preferred Label : Olendalizumab;

NCIt synonyms : Lendalizumab; Immunoglobulin, Anti-(human complement C5a) (human-mus musculus ALXN1007 heavy chain), Disulfide with Human-mus Musculus ALXN1007 Kappa-chain, Dimer;

NCIt definition : A humanized monoclonal antibody directed against the complement protein C5a, with potential immunomodulating and anti-inflammatory activities. Upon administration, olendalizumab targets and binds to C5a. This prevents the binding of C5a to its receptor C5a receptor (C5aR) and prevents C5a/C5aR-mediated pro-inflammatory signaling, thereby reducing inflammation and tissue and organ damage. C5a, a factor in the complement cascade, plays important roles in inflammation and immunity.;

UNII : 4971UQC7F3;

CAS number : 1337966-73-0;

Molecule name : ALXN 1007; ALXN-1007;

Details


You can consult :


Nous contacter.
11/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.